Finance

Beta
Lists
CNSP:NASDAQ
CNS Pharmaceuticals Inc
$4.82
-0.82%
(-0.040) 1D
Jul 15, 11:39:11 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNSP...
Open
$4.91
High
$4.91
Low
$4.76
Mkt. cap
7.04M
Avg. vol.
15.30K
Volume
2.63K
52-wk high
$11.16
52-wk low
$1.90
EPS
-$29.18
Beta
1.02
Shares outstanding
1.46M
No. of employees
8
Open
$4.91
High
$4.91
Low
$4.76
Mkt. cap
7.04M
Avg. vol.
15.30K
Volume
2.63K
52-wk high
$11.16
52-wk low
$1.90
EPS
-$29.18
Beta
1.02
Shares outstanding
1.46M
No. of employees
8
News stories
From sources across the web
About CNS Pharmaceuticals Inc
CEO-
Employees8
Founded2017
HeadquartersHouston, Texas, United States
SectorPharmaceutical industry
Analyst ratings
Based on 1 analyst giving stock ratings to CNSP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CNSP in the last 3 months
Highest
Current $4.82
$10.00 (+107.47%)
Average
$10.00 (+107.47%)
Lowest
$10.00 (+107.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+107.5%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.17M
2.20M
3.17M
3.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24M
1.06M
2.82M
1.43M
Operating expense
2.41M
3.25M
5.99M
4.98M
Total operating expenses
2.41M
3.25M
5.99M
4.98M
Operating income
-2.41M
-3.25M
-5.99M
-4.98M
Other non operating income
-
-
-2.56K
-
EBT including unusual items
-2.37M
-3.22M
-5.96M
-4.94M
EBT excluding unusual items
-2.37M
-3.22M
-5.96M
-4.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.37M
-3.22M
-5.96M
-4.94M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
38.61K
37.02K
35.60K
44.27K
Interest expense
-4.18K
-2.12K
-2.72K
-6.11K
Net interest expenses
34.42K
34.91K
32.88K
38.16K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.41M
-3.25M
-5.99M
-4.97M
Gain or loss from assets sale
-
-
2.56K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more